This crash will look like a blip

Swiss-listed BB Biotech celebrates 30 years of outperformance with fund manager Dr Daniel Koller confident the biotechnology slump of the past two years will in time look like a small setback.

What is Citywire: The Funds Fanatic Show?

Citywire's Funds Fanatic Show brings investors the latest news and views on funds and investment trusts.